Laura Clarke

Laura Clarke has a strong background in scientific research and has worked in various roles within the pharmaceutical and academic sectors. Laura began their career as an Industrial Placement Student at Novartis Institutes for BioMedical Research (NIBR) in 2005. Laura then pursued their education and obtained a Neuroscience Ph.D from UCL, where they were a student from 2007 to 2012.

After completing their Ph.D, Laura joined Stanford University as a Postdoctoral Scholar in 2012 and worked there until 2019. During this time, they gained valuable experience in their field. In 2019, they transitioned to Denali Therapeutics, where they held the position of Project team leader and Scientist. Their work at Denali lasted until 2023, during which they demonstrated strong leadership skills and contributed to various projects.

Currently, Laura is employed as a Principal Scientist at Lyterian Therapeutics since June 2023. With their extensive experience and expertise, they are well-positioned to contribute to the scientific advancements in their field.

Laura Clarke completed their Bachelor of Science in Pharmacology at The University of Manchester in 2007. Subsequently, they pursued a Doctor of Philosophy in Neuroscience at UCL starting in 2012. There is no information available regarding their education at Stanford University.